TransCode Therapeutics, Inc. Announces Closing of Registered Direct Offering
Press Releases
TransCode Therapeutics, Inc.  
March 25, 2025

TransCode Therapeutics, Inc. Announces Closing of Registered Direct Offering

BOSTON, March 25, 2025 /PRNewswire/ -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ), ("TransCode" or the "Company"), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced

avatar profile Olean Times Herald

Olean Times Herald


Local & Social